Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Debt Ratio (2022 - 2025)

Historic Debt Ratio for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to 0.27.

  • HCW Biologics' Debt Ratio rose 1205.15% to 0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27, marking a year-over-year increase of 1205.15%. This contributed to the annual value of 0.21 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' Debt Ratio is 0.27, which was up 1205.15% from 0.22 recorded in Q2 2025.
  • HCW Biologics' 5-year Debt Ratio high stood at 0.82 for Q4 2022, and its period low was 0.0 during Q1 2023.
  • Over the past 4 years, HCW Biologics' median Debt Ratio value was 0.21 (recorded in 2024), while the average stood at 0.18.
  • Per our database at Business Quant, HCW Biologics' Debt Ratio surged by 712604.1% in 2024 and then soared by 1205.15% in 2025.
  • Quarter analysis of 4 years shows HCW Biologics' Debt Ratio stood at 0.82 in 2022, then plummeted by 99.6% to 0.0 in 2023, then surged by 6220.71% to 0.21 in 2024, then increased by 28.1% to 0.27 in 2025.
  • Its Debt Ratio stands at 0.27 for Q3 2025, versus 0.22 for Q2 2025 and 0.24 for Q1 2025.